Search the Newsreel

Zimmer (ZBH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Zimmer Biomet (ZBH) reported $2.18 billion in revenue for the quarter ended June 2026, representing a year-over-year increase of 4.8%. EPS of $2.07 for the same period compares to $2.07 a year ago. The reported revenue represents a surprise of +2.25% over the Zacks …

Zimmer Biomet raises full-year outlook after second-quarter earnings beat

Researcher looking through microscope ©Adobe Stock Images Zimmer Biomet Holdings (NYSE:ZBH) reported better-than-expected second-quarter results and increased its guidance for the full year, helping lift the medical technology company's shares more than 4% in pre-market trading. The company posted adjusted earnings of $2.07 per …

Zimmer Biomet stock rises 4% on Q2 beats, raised guidance By Investing.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) reported stronger-than-expected second-quarter results and subsequently raised its full-year guidance, leading to a 4.27% increase in pre-market trading. The medical technology company surpassed analyst consensus for both adjusted earnings per share and revenue. This positive performance was attributed to …

Zimmer Biomet (ZBH) Q2 Earnings and Revenues Beat Estimates

Zimmer Biomet (ZBH) reported strong Q2 results, with earnings of $2.07 per share and revenues of $2.18 billion, both exceeding Zacks Consensus Estimates. The company has consistently surpassed EPS estimates over the last four quarters and revenues three times. Despite underperforming the market year-to-date, …

Zimmer Biomet Q2 Adjusted Earnings Flat, Net Sales Rise; Lifts 2026 Guidance

Zimmer Biomet Holdings reported flat adjusted earnings for Q2 2026 but saw an increase in net sales. The company also raised its 2026 financial guidance following strong implant demand. Several analysts have adjusted their price targets for Zimmer Biomet in response to the earnings …

Zimmer Biomet’s (NYSE:ZBH) Q2 CY2026: Beats On Revenue

Zimmer Biomet (NYSE:ZBH) reported better-than-expected revenue in Q2 CY2026, with sales up 4.8% year-on-year to $2.18 billion, beating analyst estimates. The company's non-GAAP profit of $2.07 per share also surpassed estimates by 3%, and management slightly raised its full-year Adjusted EPS guidance. While the …

Press Release: Zimmer Biomet Announces Second Quarter 2026 Financial Results

Zimmer Biomet announced its financial results for the second quarter of 2026. The company is providing a press release detailing its performance for the quarter. This release will offer insights into the company's financial health and operational achievements.

Zimmer Biomet (NYSE: ZBH) lifts Q2 2026 earnings and cash flow

Zimmer Biomet Gets FDA 510(k) Clearance for Next-Gen ROSA Shoulder System

Zimmer Biomet (NYSE: ZBH) exec vests 9,957 RSUs, with 4,266 shares withheld

Kevin R. Thornal, Group President-Global Business at Zimmer Biomet Holdings, Inc. (NYSE: ZBH), exercised 9,957 Restricted Stock Units (RSUs) into common stock on August 1, 2026. To cover tax obligations, 4,266 shares were withheld at $92.68 per share. Following this transaction, Thornal holds 19,913 …

Zimmer Biomet faces earnings test as growth questions persist

Zimmer Biomet is set to report its second-quarter earnings, with investors focused on whether its strategic transformation, including sales force restructuring and robotics investments, is accelerating growth. Analysts expect earnings of $2.01 per share on revenue of $2.14 billion, with organic growth remaining a …

3 Healthcare Stocks We Find Risky

3 Healthcare Stocks We Find Risky Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 16.6% over the past six months, …

Zimmer Biomet (ZBH) Q2 Earnings: What To Expect

XS207910589 Bond Profile — Key Metrics

This article provides key metrics for the Zimmer Biomet Holdings, Inc. bond with ISIN XS207910589. It details the bond's coupon rate, issue and maturity dates, outstanding amount, face value, and minimum denomination. The company, Zimmer Biomet Holdings, Inc., is described as a designer, manufacturer, …

Zimmer Biomet Holdings Inc. stock underperforms Friday when compared to competitors

Zimmer Biomet Holdings Inc. (ZBH) stock fell 1.08% on Friday, closing at $93.93, despite a generally positive trading day for the broader market. Both the S&P 500 Index and the Dow Jones Industrial Average saw gains. This marked the second consecutive day of losses …

Possible Bearish Signals With Zimmer Biomet Holdings Insiders Disposing Stock

This article analyzes recent insider selling at Zimmer Biomet Holdings, where insiders disposed of shares worth US$4.4 million over the last year. Despite the selling, the company's stock is up 12% in the past year, indicating that insider selling alone isn't a strong indicator …

Zimmer Biomet Holdings Inc. stock outperforms competitors despite losses on the day

Zimmer Biomet Holdings Inc. (ZBH) saw its stock decline by 2.25% to $94.96, ending a five-day winning streak. This occurred despite a generally favorable trading session for the broader market, with the S&P 500 Index and Dow Jones Industrial Average both posting gains. The …

Zimmer Biomet (ZBH) Is Up 7.7% After Q1 Beat And Confident Outlook Commentary - What's Changed

Zimmer Biomet (ZBH) saw its stock rise by 7.7% following a strong first-quarter performance, with revenues up 9.3% year-on-year and earnings surpassing analyst expectations. The company's confident outlook, driven by its robotics and efficiency investments, reinforces its investment narrative despite potential risks from pricing …

ZIMMER BIOMET HOLDINGS, INC : UBS ASSUMES COVERAGE WITH BUY VS SELL RATING; PRICE TARGET $115 VS $89

UBS has initiated coverage on Zimmer Biomet Holdings, Inc. with a "Buy" rating, significantly increasing its price target to $115 from a previous "Sell" rating and target of $89. This upgrade from UBS indicates a positive outlook for the company's stock.

Zimmer Biomet Set to Report Q2 Earnings: What's in the Cards?

Zimmer Biomet (ZBH) is expected to report its second-quarter 2026 earnings on August 5th, with revenue estimates of $2.13 billion and EPS of $2.01. The company's performance is anticipated to be driven by strong demand in its Knees, Hips, S.E.T (Sports Medicine, Upper Extremities, …

Zimmer Biomet Holdings Inc (ZBH) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Zimmer Biomet Holdings Inc (ZBH), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. The analysis suggests the stock is currently suitable for range-bound swing trading, with …

Zimmer Biomet (ZBH) to Post Earnings on Wednesday

Zimmer Biomet Shares Rise After UBS Upgrade

Zimmer Biomet shares experienced a rise after UBS upgraded the company's stock. This upgrade by UBS indicates a more positive outlook on Zimmer Biomet's financial prospects and market position.

Zimmer upgraded to Buy from Sell at UBS on growth and innovation

[Zimmer Biomet office in Mississauga, Ontario, Canada.] JHVEPhoto/iStock Editorial via Getty Images Zimmer Biomet (ZBH [https://seekingalpha.com/symbol/ZBH]) traded higher on Tuesday after UBS analyst Patrick Wood assumed its coverage and upgraded the stock to Buy from Sell, citing the orthopedic product maker’s growth prospects and …

UBS initiates Zimmer Biomet stock coverage with buy rating By Investing.com

UBS has initiated coverage on Zimmer Biomet Holdings Inc. (NYSE:ZBH) with a "buy" rating and a price target of $115, citing the company's sales force restructuring and its Monogram autonomous robot as key drivers for future growth. The investment bank anticipates significant upside potential …

Zimmer Biomet Holdings, Inc. $ZBH Shares Bought by First Trust Advisors LP

First Trust Advisors LP increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 23.2% in the first quarter, now owning 387,537 shares valued at over $35 million. Several other hedge funds also adjusted their holdings, with institutional investors collectively owning 88.89% of the …

Gabelli Funds LLC Boosts Stock Holdings in Zimmer Biomet Holdings, Inc. $ZBH

Gabelli Funds LLC significantly increased its stake in Zimmer Biomet Holdings, Inc. by 13% in the first quarter, bringing its total holdings to 147,350 shares valued at $13.3 million. Despite a generally cautious analyst outlook, Zimmer Biomet reported strong quarterly earnings, beating estimates with …

Zimmer Biomet Holdings Inc (ZBH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Zimmer Biomet Holdings Inc (ZBH), highlighting its major institutional investors and their respective holdings. It also breaks down shareholder types and provides a quarterly overview of institutional shareholding trends and changes in individual shareholder activity.

Zimmer Biomet Holdings Inc (ZBH) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts for Zimmer Biomet Holdings Inc (ZBH), detailing past and upcoming interim and final cash dividends. It lists dividend amounts, record dates, payment dates, and ex-dividend dates for quarterly payouts, consistently showing a gross dividend of …

Zimmer Biomet Holdings Inc (ZBH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Zimmer Biomet Holdings Inc (ZBH), detailing its performance by business segments and regional contributions. As of a recent update, the company's revenue is primarily driven by its Knees, S E T, and Hips product categories, with the …

Zimmer Biomet stock trades steady as hip and knee demand supports guidance

Zimmer Biomet's stock remains stable as demand for orthopedic implants, particularly hip and knee replacements, continues to drive positive financial results. The company reported a 3% increase in Q1 2024 revenue to $1.89 billion and improved operating margins, signaling efficient management of procedural volumes …

How Zimmer Biomet’s New Asia Pacific President Shapes Its Robotics and Regional Strategy for ZBH Investors

Zimmer Biomet Holdings (ZBH) has appointed Chintan Desai as the new president of its Asia Pacific region, effective July 14, 2026. Desai's extensive MedTech experience in the region is expected to significantly influence Zimmer Biomet's robotics-focused investment strategy and its execution in this key …

Zimmer Biomet Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains

Shares of Zimmer Biomet Holdings Inc. (ZBH) rose 1.09% on Thursday, closing at $89.65 despite a general market downturn. Although the stock saw daily gains, it underperformed compared to some competitors. This slight increase broke a four-day losing streak for the company's stock.

Zimmer Biomet (NYSE: ZBH) executive Desai Chintan files initial Form 3

Zimmer Biomet Holdings, Inc. executive Desai Chintan, President, APAC, has filed an initial Form 3, an ownership report indicating no stock transactions, holdings, or derivative positions for Zimmer Biomet securities. This filing, accepted by the SEC on July 23, 2026, establishes his reporting person …

XS153277974 Bond Profile — Key Metrics

This article provides a profile of the Zimmer Biomet Holdings, Inc. bond XS153277974, detailing key metrics such as its 2.425% coupon, a maturity date of December 13, 2026, and an outstanding amount of 500 million EUR. It also includes an overview of Zimmer Biomet …

Zimmer Biomet Holdings (ZBH) Could Be 9% Undervalued After Asia Pacific Leadership Change

Zimmer Biomet Holdings (ZBH) has appointed Chintan Desai as president of its Asia Pacific Region, a leadership change that comes as the stock trades at US$89.72, with a 30-day share price return of 1.99%. Despite recent short-term momentum, the company's 1-year total shareholder return …